CMS-10540 QIS Progress Report

Quality Improvement Strategy Implementation Plan and Progress Report (CMS-10540)

CMS-10540 - 2025 Progress Report Form

Quality Improvement Strategy Implementation Plan and Progress Report Form

OMB: 0938-1286

Document [pdf]

Download: pdf | pdf

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX

QIS Progress Report Form
Submission date (please indicate the date you are
submitting this QIS form via HIOS or SERFF)

Use this form to report on progress made during the previous year of your quality improvement strategy
(QIS). Please refer to your baseline QIS Implementation Plan and any subsequent modifications for
baseline data.
Confirm you have reviewed your baseline QIS Implementation Plan (and associated Modification
Summary Supplement, if applicable) in preparing this submission.
For detailed instructions, please refer to the Quality Improvement Strategy: Technical Guidance and User
Guide for the current plan year on the Marketplace Quality Initiatives website.
PLEASE NOTE: Both issuers who are CONTINUING or DISCONTINUING a QIS need to submit a
Progress Report form. There are two scenarios for issuers:
1. Progress Report: Issuers who are continuing their current QIS (with or without modifications)
should select Progress Report to report on progress made during the previous year of your QIS.
2. Progress Report Closeout Form: Issuers discontinuing their current QIS and implementing a
new one should select Progress Report Closeout Form and submit the Progress Report form to
close out the discontinued QIS. These issuers should also describe the QIS that will be in place
for the 2025 Plan Year by submitting a QIS Implementation Plan for the new QIS.

For CMS Use Only

pg. 1

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control
number. The valid OMB control number for this information collection is 0938-1286. This information collection is required for issuers applying for QHP
certification in applicable Exchanges that meet the QIS participation criteria, in accordance with section 1311(g) of the PPACA. CMS will assess responses for
completeness, evaluate them against QIS requirements, and confidentially report results to issuers. The time required to complete this information collection is
estimated to average 18 hours per response, including the time to review instructions, search existing data resources, gather the data needed, to review and
complete the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to:
CMS, 7500 Security Boulevard, Mail Stop C4-26-05, Baltimore, Maryland 21244-1850 Attn: PRA Reports Clearance Officer.

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX

QIS Submission Type
Part A. Progress Report or Closeout QIS Submission
These fields are required but will not be scored as part of the QIS evaluation.
1. Type of QIS Submission
Select the option that describes the type of QIS submission and follow the instructions to complete
the submission.
Type of QIS

Instructions

Progress Report

Issuers must complete one 1 form:
1. Complete the Background Information section (Parts A and B), and
the Progress Report Summary section (Part C) of the Progress
Report form to report progress on your baseline QIS.

Progress Report Closeout
Form

Issuers must complete 2 forms:
1. Complete the Background Information section (Parts A and B) and
the Progress Report Summary section (Part C) of the Progress
Report form to close out the discontinued QIS, reporting on progress
up until the strategy was discontinued.
2. Complete a new Implementation Plan form. See instructions in the
QIS Implementation Plan form: New QIS after Discontinuing a QIS
Submitted During a Prior QHP Application Period.

QIS Title
Restate the short title for the QIS being reported on. (200-character limit)

If continuing with modifications, issuers must also complete a Modification Summary Supplement form. See
instructions in the QIS Modification Summary Supplement form: Continuing a QIS with Modifications.

pg. 2

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX

Background Information
Part B. Issuer Information
These fields are required but will not be scored as part of the QIS evaluation. Issuers may update the
information in Part B from year to year, as needed.
2. Issuer Legal Name

3. Company Legal Name

4. HIOS Issuer ID

5. Issuer State

6. QIS Primary Contact’s First Name
7. QIS Primary Contact’s Title

QIS Primary Contact’s Last Name
8. QIS Primary Contact’s Phone

Ext.

9. QIS Primary Contact’s Email
10. QIS Secondary Contact’s First Name
11. QIS Secondary Contact’s Title

QIS Secondary Contact’s Last Name
12. QIS Secondary Contact’s Phone

Ext.

13. QIS Secondary Contact’s Email
14. Date Issuer Began Offering Coverage Through the Exchange
Note: For all date fields in this form, use the down arrow key to activate
the calendar and then use the mouse or arrow keys to navigate to the
correct date.

pg. 3

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
15. Current Payment Model(s) Description
Select the category(ies) of payment models that are used by the issuer across its Exchange product
line. Provide the percentage of payments in each payment model category 2 used by the issuer across
its Exchange product line. The total percentage of payments across all four payment model types
should equal approximately 100 percent. 3
Note: These percentages can be estimates and do not need to be exact figures. Issuers may update
this information year to year, as needed.
Payment Model Type

Payment Model Description

Provide Percentage

Fee for Service –
No Link to Quality and
Value

Payments are based on volume of
services and not linked to quality or
efficiency.

Fee for Service – Linked
to Quality and Value

At least a portion of payments vary
based on the quality or efficiency of
health care delivery.

Alternative Payment
Models Built on Fee for
Service Architecture

Some payment is linked to the
effective management of a segment of
the population or an episode of care.
Payments are still triggered by delivery
of services, but there are opportunities
for shared savings or two-sided risk.

Population-based
Payment

Payment is not directly triggered by
service delivery, so payment is not
linked to volume. Clinicians and
organizations are paid and responsible
for the care of a beneficiary for a long
period (e.g., more than one year).

Total

Please confirm the total percentage of
payments across all four payment
model type categories equals
approximately 100%.

Categories of payment models are defined in the Alternative Payment Model Framework and Progress Tracking
(APM FPT) Work Group – Alternative Payment Model (APM) Framework Final White Paper, available at: https://hcplan.org/workproducts/apm-whitepaper.pdf. See the QIS Technical Guidance and User Guide for the current plan year,
available on the Marketplace Quality Initiatives website, for examples of payment models within each category.
3 To calculate the percentage of payments for Fee for Service payments linked to quality or value, and/or Alternative
Payment Models tied to quality or value, issuers should use the calculation methodologies defined in the Measuring
Progress: Adoption of Alternative Payment Models in Commercial, Medicare Advantage, and State Medicaid
Programs (APM Measurement Effort) Final Paper, available at: https://hcp-lan.org/groups/apm-fpt/apm-report/. See
Table 1 (p. 7-10) for instructions to calculate the percentage of payments for these two payment model categories.
2

pg. 4

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX

QIS Progress Report Section
Part C. QIS Progress Report Summary
The Elements in Part C will be scored as part of the QIS evaluation.
Note: The Goal(s) and Measure(s) identified in this section (Part C: Progress Report Summary) are the
Goal(s) and Measure(s) from the Implementation Plan form (and associated Modification Summary
Supplement, if applicable) on file against which QIS progress is measured.
Note: All references to Implementation Plan form elements and criteria in this form refer to the
Implementation Plan form (and associated Modification Summary Supplement, if applicable) on file.
Note: Please make sure to correctly restate the values and information from the most recent
Implementation Plan on file and/or the Modification Summary Supplement on file, when
applicable.
16. Analyze Progress Using Baseline Data, as Documented in the Implementation Plan
(Must Pass)
Restate Goal 1 identified in the Implementation Plan or the Modification Summary Supplement on file,
if applicable.
QIS Goal 1:
(500 character limit)

Measure 1a:
16a. Restate Measure 1a name from the Implementation Plan or the Modification Summary
Supplement on file, if applicable:

If this a consensus-based entity (CBE)-endorsed measure, 4 please provide the 4-digit CBE-ID
number:

The CBE sets measure evaluation criteria through experts and multi-stakeholder groups involved in the evaluation
process. For further details regarding CBE endorsed quality measures, please visit the CBE measure database
(http://www.p4qm.org/measures).

pg. 5

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
16b. Baseline Assessment: Restate the baseline results from the Implementation Plan or the
Modification Summary Supplement on file, if applicable, by either:
•

Calculating the rate and providing the associated numerator and denominator:
(Note: The numerator and denominator should calculate to the rate provided.)
Calculated Rate:
Numerator:
Denominator:
- OR -

•

Indicating the data point if the measure is not a rate:
Data Point:

16c. Provide the baseline performance period (i.e., month and year when data collection began and
ended) covered by the baseline assessment provided in the Implementation Plan or the
Modification Summary Supplement on file, if applicable:

16d. Provide the Progress Report results by either:
•

•

Indicating the data point if the measure is not a rate:
Data Point:

16e. Provide the Progress Report performance period (i.e., month and year when data collection
began and ended) covered by the progress report assessment:

16f.

Restate the numerical value performance target for this measure (i.e., the target rate or data
point the QIS intends to achieve) from the Implementation Plan or the Modification Summary
Supplement on file, if applicable: (Note: This entry should be a rate (%) or a data point target,
NOT a percentage change.)

pg. 6

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
16g. Was the performance target achieved?
Yes

Measure 1b:
16h. Restate Measure 1b name from the Implementation Plan or the Modification Summary
Supplement on file, if applicable:

If this a consensus-based entity (CBE)-endorsed measure, please provide the 4-digit CBE-ID
number:

16i.

Baseline Assessment: Restate the baseline results from the Implementation Plan or the
Modification Summary Supplement on file, if applicable, by either:
•

•

Indicating the data point, if the measure is not a rate:
Data Point:

16j.

Provide the baseline performance period (i.e., month and year when data collection began and
ended) covered by the baseline assessment provided in of the Implementation Plan or the
Modification Summary Supplement on file, if applicable:

16k. Provide the Progress Report results by either:
•

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
•

Indicating the data point if the measure is not a rate:
Data Point:

16l.

Provide the Progress Report performance period (i.e., month and year when data collection
began and ended) covered by the progress report assessment:

16m. Restate the numerical value performance target for this measure (i.e., the target rate or data
point the QIS intends to achieve) from the Implementation Plan or the Modification Summary
Supplement on file, if applicable: (Note: This entry should be a rate (%) or a data point target,
NOT a percentage change.)

16n.

Was the performance target achieved?
Yes

QIS Goal 2
Restate Goal 2 identified in the Implementation Plan or the Modification Summary Supplement on file,
if applicable.
QIS Goal 2:
(500 character limit)

Measure 2a:
16o. Restate Measure 2a name from the Implementation Plan or the Modification Summary
Supplement on file, if applicable:

If this a consensus-based entity (CBE)-endorsed measure, please provide the 4-digit CBE-ID
number:

pg. 8

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
16p. Baseline Assessment: Restate the baseline results from the Implementation Plan or the
Modification Summary Supplement on file, if applicable, by either:
•

•

Indicating the data point if the measure is not a rate:
Data Point:

16q. Provide the baseline performance period (i.e., month and year when data collection began and
ended) covered by the baseline assessment provided in the Implementation Plan or the
Modification Summary Supplement on file, if applicable:

16r.

Provide the Progress Report results by either:
•

•

Indicating the data point if the measure is not a rate:
Data Point:

16s. Provide the Progress Report performance period (i.e., month and year when data collection
began and ended) covered by the progress report assessment:

16t. Restate the numerical value performance target for this measure (i.e., the target rate or data
point the QIS intends to achieve) from the Implementation Plan or the Modification Summary
Supplement on file, if applicable: (Note: This entry should be a rate (%) or a data point target,
NOT a percentage change.)

pg. 9

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
16u. Was the performance target achieved?
Yes

Measure 2b:
16v. Restate Measure 2b name from the Implementation Plan or the Modification Summary
Supplement on file, if applicable:

If this a consensus-based entity (CBE)-endorsed measure, please provide the 4-digit CBE-ID
number:

16w. Baseline Assessment: Restate the baseline results from the Implementation Plan or the
Modification Summary Supplement on file, if applicable, by either:
•

•

Indicating the data point if the measure is not a rate:
Data Point:

16x. Provide the baseline performance period (i.e., month and year when data collection began and
ended) covered by the baseline assessment provided in the Implementation Plan or the
Modification Summary Supplement on file, if applicable:

16y. Provide the Progress Report results by either:
• Calculating the rate and providing the associated numerator and denominator:
(Note: The numerator and denominator should calculate to the rate provided.)
Calculated Rate:
Numerator:
Denominator:
- OR • Indicating the data point if the measure is not a rate:
Data Point:
pg. 10

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
16z. Provide the Progress Report performance period (i.e., month and year when data collection
began and ended) covered by the progress report assessment:

16aa. Restate the numerical value performance target for this measure (i.e., the target rate or data
point the QIS intends to achieve) from the Implementation Plan or the Modification Summary
Supplement on file, if applicable: (Note: This entry should be a rate (%) or a data point target,
NOT a percentage change.)

16bb. Was the performance target achieved?
No
Yes
17. Summary of Progress (Must Pass)
17a. Please provide a summary of progress covering the following details: (Note: Regardless of if
you made progress toward the performance target(s), you will be required to describe any
barriers encountered in Criterion 18a and any problems meeting timelines in Criterion 18b.)
•

Indicate why progress was or was not made toward the performance target(s)
documented in your QIS Implementation Plan or the Modification Summary Supplement
on file, if applicable, and

•

Include a description of activities that led to the outcome.

(1,000 character limit)

pg. 11

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
17b. If the issuer selected "Progress Report Closeout Form" in Element 1 of this Progress Report
form, provide the rationale for discontinuing the QIS.
(1,000 character limit)

17c. If the issuer received an “Interim Meets” determination during the previous QIS Evaluation
Period and was instructed to address the deficiencies in its subsequent Plan Year submission,
please indicate which elements and/or criteria were updated based on the QIS Evaluation
Period Correction Report and describe the changes.
(1,000 character limit)

pg. 12

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
18. Barriers and Mitigation Activities
18a. Were barriers encountered in implementing the QIS over time? (Note: If your description of
activities in Criterion 17a includes barriers to implementing the QIS, you are still required to
complete Criterion 18a and elaborate on those barriers and any other barriers in implementing
the QIS, if applicable, by providing the below information.)
No

Yes
If “Yes,” describe:
•

The barriers, and

•

The mitigation activities implemented to address each barrier.

(1,500-character limit)

pg. 13

2025 Plan Year
Draft QIS Progress Report Form
OMB 0938-1286
Expiration Date: XX/XX/20XX
18b. Were there problems meeting timelines as indicated in the QIS Implementation Plan on file?
(Note: If your description of activities in Criterion 17a includes problems meeting timelines, you
are still required to complete Criterion 18b and elaborate on those problems and any other
problems in meeting timelines, if applicable, by providing the below information.)
No

Yes
If “Yes,” describe:
•
•

The problems in meeting timelines and
The mitigation activities implemented to address each problem in meeting the timeline.

(1,500-character limit)

Optional: If there is any additional information you would like to provide regarding your QIS Progress
Report, please do so in the box below.
(1,500 character limit)

pg. 14

File Type	application/pdf
File Title	2025 Plan Year QIS Progress Report
Subject	QIS Progress Report
Author	Centers for Medicare & Medicaid Services
File Modified	2024-08-14
File Created	2024-02-29